APOBEC3A expression was not initially detectable in breast cancer cell lines [5], and APOBEC3B expression correlates strongly with overall mutations in multiple malignancies [5, 14], leading many to initially believe that APOBEC3B is responsible for the majority of the APOBEC mutational signature. This evidence concerns the gene APOBEC3A and breast carcinoma.